MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

TLRY

9.12

+5.43%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

TLRY

9.12

+5.43%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

TLRY

9.12

+5.43%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

TLRY

9.12

+5.43%↑

MDT

101.45

+0.95%↑

A

138.61

-0.74%↓

VEEV

225

+2.37%↑

HQY

86.43

+2.1%↑

TLRY

9.12

+5.43%↑

Search

Neogen Corp

Fermé

SecteurSoins de santé

9.92 0.61

Résumé

Variation du prix de l'action

24h

Actuel

Min

9.71

Max

10.08

Chiffres clés

By Trading Economics

Revenu

-52M

-16M

Ventes

16M

225M

Marge bénéficiaire

-7.087

Employés

2,974

EBITDA

-66M

23M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+14.12% upside

Dividendes

By Dow Jones

Prochains Résultats

8 avr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

435M

2B

Ouverture précédente

9.31

Clôture précédente

9.92

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Neogen Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

22 janv. 2026, 21:55 UTC

Résultats

Capital One Financial Posts Higher 4Q Profit As Lending Increases

22 janv. 2026, 23:52 UTC

Résultats

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- Update

22 janv. 2026, 23:48 UTC

Market Talk

Nikkei May Rise as Tensions Between U.S. and Europe Ease -- Market Talk

22 janv. 2026, 23:42 UTC

Market Talk

Gold Edges Lower on Possible Profit-Taking -- Market Talk

22 janv. 2026, 23:40 UTC

Market Talk

Spark NZ's Market Share Loss Concerns Bear -- Market Talk

22 janv. 2026, 23:30 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

22 janv. 2026, 23:30 UTC

Market Talk

Genesis Energy Can Beat Newly Upgraded Earnings Goal -- Market Talk

22 janv. 2026, 22:37 UTC

Market Talk
Acquisitions, Fusions, Rachats

Capital One CEO: Brex Buy Reflects Business Payments Focus -- Market Talk

22 janv. 2026, 21:59 UTC

Acquisitions, Fusions, Rachats

Capital One Strikes $5.15 Billion Deal for Fintech Brex -- Update

22 janv. 2026, 21:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Tech, Media & Telecom Roundup: Market Talk

22 janv. 2026, 21:44 UTC

Résultats

Self-Driving Stock Mobileye Plunged After Earnings. Here's Why. -- Barrons.com

22 janv. 2026, 21:32 UTC

Acquisitions, Fusions, Rachats

Capital One: Brex Invented Integrated Combination of Corporate Credit Cards, Spend Management Software and Banking in Single Platform >COF

22 janv. 2026, 21:31 UTC

Acquisitions, Fusions, Rachats

Capital One: Brex Is a Modern, AI-native Software Platform Offering Intelligent Finance Solutions >COF

22 janv. 2026, 21:31 UTC

Acquisitions, Fusions, Rachats

Capital One: Franceschi Will Continue to Lead Brex as Part of Capital One >COF

22 janv. 2026, 21:30 UTC

Acquisitions, Fusions, Rachats

Capital One to Acquire Brex in Combination of Stk and Cash Transaction Valued at $5.15 B >COF

22 janv. 2026, 21:30 UTC

Résultats

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results -- WSJ

22 janv. 2026, 21:30 UTC

Acquisitions, Fusions, Rachats

Capital One To Acquire Brex >COF

22 janv. 2026, 21:13 UTC

Résultats

Intel Returns to Losses in Q4 as It Ramps Up Spending on Chip Production -- WSJ

22 janv. 2026, 21:11 UTC

Résultats

Intuitive Surgical Sees 2026 Impact From Tariffs 1.2% of Revenue, Plus or Minus 10 Basis Points >ISRG

22 janv. 2026, 21:11 UTC

Résultats

Intuitive Surgical Sees 2026 Adjusted Gross Profit Margin 67%-68% >ISRG

22 janv. 2026, 21:10 UTC

Résultats

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of 13%-15% >ISRG

22 janv. 2026, 21:06 UTC

Résultats

Capital One 4Q Total Non-Interest Expense Increased 13% to $9.3B >COF

22 janv. 2026, 21:05 UTC

Résultats

Capital One 4Q Provision for Credit Losses Increased $4.1B >COF

22 janv. 2026, 21:05 UTC

Résultats

Capital One 4Q Rev $15.58B >COF

22 janv. 2026, 21:05 UTC

Résultats

Capital One 4Q EPS $3.26 >COF

22 janv. 2026, 21:05 UTC

Résultats

Capital One 4Q Net Interest Margin 8.26% >COF

22 janv. 2026, 21:05 UTC

Résultats

Capital One 4Q Net $2.13B >COF

22 janv. 2026, 21:05 UTC

Résultats

Capital One 4Q Adj EPS $3.86 >COF

22 janv. 2026, 21:05 UTC

Résultats

Capital One 4Q Net Charge-Offs $3.8B >COF

22 janv. 2026, 21:05 UTC

Résultats

Intuitive Surgical 4Q EPS $2.21 >ISRG

Comparaison

Variation de prix

Neogen Corp prévision

Objectif de Prix

By TipRanks

14.12% hausse

Prévisions sur 12 Mois

Moyen 10.67 USD  14.12%

Haut 12 USD

Bas 10 USD

Basé sur 4 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

4 ratings

2

Achat

2

Maintien

0

Vente

Score Technique

By Trading Central

5.17 / 5.99Support & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Weak Bearish Evidence

Long Terme

Weak Bearish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Neogen Corp

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared food products and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. The company was incorporated in 1981 and is headquartered in Lansing, Michigan.
help-icon Live chat